Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IDP-110 in Acne Vulgaris
NCT00664248Phase 3Completed
- Sponsor
- Dow Pharmaceutical Sciences
- Start
- Oct 2006
- Primary completion
- Aug 2007
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of clindamycin phosphate + benzoyl peroxide in acne vulgaris, sponsored by Dow Pharmaceutical Sciences. Started Oct 2006; status: completed.
02
Drugs
clindamycin phosphate + benzoyl peroxide
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT00664248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00664248.